Overview on (treatment-related) AEs and serious AEs
| CTCAE terminology . | SAEs, n (%) . | AEs, n (%) . | CTC grade . | Related to anti-CD20 Ab (%) . |
|---|---|---|---|---|
| Neutropenia | 1 (8) | 4 | 1/1 (100) | |
| Pneumonia | 4 (33) | 3 | 0/4 (0) | |
| Pleural/pericardial effusion | 1 (8) | 3 | 1/1 (100) | |
| Colorectal carcinoma | 1 (8) | 3 | 0/1 (0) | |
| Atrial fibrillation | 1 (8) | 3 | 0/1 (0) | |
| Autoimmune hemolytic anemia | 1 (8) | 3 | 0/1 (0) | |
| Sepsis | 1 (8) | 3 | 0/1 (0) | |
| Acute kidney injury | 1 (8) | 3 | 0/1 (0) | |
| Herpes zoster | 1 (8) | 3 | 0/1 (0) | |
| Hyponatremia | 1 (8) | 3 | 0/1 (0) | |
| Neutropenia | 2 (17) | 3 | 2/2 (100) | |
| Richter transformation | 1 (8) | 3 | 0/1 (0) | |
| Neuritis vestibularis | 1 (8) | 3 | 0/1 (0) | |
| Anemia | 2 (17) | 3 | 2/2 (100) | |
| Infusion-related reaction | 1 (8) | 3 | 1/1 (100) | |
| Chronic cutaneous GVHD | 1 (8) | 3 | 0/1 (0) | |
| Pyoderma gangrenosum | 1 (8) | 3 | 0/1 (0) | |
| Femoral head necrosis | 1 (8) | 3 | 0/1 (0) | |
| Basal cell carcinoma | 1 (8) | 2 | 0/1 (0) | |
| Bronchopulmonary infection | 2 (17) | 1 | 2/2 (100) | |
| Total | 21 | 7 |
| CTCAE terminology . | SAEs, n (%) . | AEs, n (%) . | CTC grade . | Related to anti-CD20 Ab (%) . |
|---|---|---|---|---|
| Neutropenia | 1 (8) | 4 | 1/1 (100) | |
| Pneumonia | 4 (33) | 3 | 0/4 (0) | |
| Pleural/pericardial effusion | 1 (8) | 3 | 1/1 (100) | |
| Colorectal carcinoma | 1 (8) | 3 | 0/1 (0) | |
| Atrial fibrillation | 1 (8) | 3 | 0/1 (0) | |
| Autoimmune hemolytic anemia | 1 (8) | 3 | 0/1 (0) | |
| Sepsis | 1 (8) | 3 | 0/1 (0) | |
| Acute kidney injury | 1 (8) | 3 | 0/1 (0) | |
| Herpes zoster | 1 (8) | 3 | 0/1 (0) | |
| Hyponatremia | 1 (8) | 3 | 0/1 (0) | |
| Neutropenia | 2 (17) | 3 | 2/2 (100) | |
| Richter transformation | 1 (8) | 3 | 0/1 (0) | |
| Neuritis vestibularis | 1 (8) | 3 | 0/1 (0) | |
| Anemia | 2 (17) | 3 | 2/2 (100) | |
| Infusion-related reaction | 1 (8) | 3 | 1/1 (100) | |
| Chronic cutaneous GVHD | 1 (8) | 3 | 0/1 (0) | |
| Pyoderma gangrenosum | 1 (8) | 3 | 0/1 (0) | |
| Femoral head necrosis | 1 (8) | 3 | 0/1 (0) | |
| Basal cell carcinoma | 1 (8) | 2 | 0/1 (0) | |
| Bronchopulmonary infection | 2 (17) | 1 | 2/2 (100) | |
| Total | 21 | 7 |
CTC, Common Terminology Criteria; CTCAE, Common Terminology Criteria for AEs; GVHD, graft-versus-host disease; SAEs, serious AEs.